UBS Group »

Kinnate Biopharma shares owned by UBS Group

Quarter-by-quarter ownership of Kinnate Biopharma (KNTE) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Kinnate Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Kinnate Biopharma held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kinnate Biopharma by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $12k 5.1k 2.37
2021-09-30 $17k 730 23.29
2021-06-30 $6.0k 252 23.81
2021-03-31 $25k 788 31.73
2020-12-31 $1.6M 40k 39.77